Relationship Between Health-Related Quality of Life and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients With No Prior Chemotherapy: Results From Prevail Study

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Mp52-19 Impact of Enzalutamide on Pain and Health-Related Quality of Life in Men With Non-Metastatic Castration-Resistant Prostate Cancer: Prosper Study Results

Journal of Urology
Urology
2018English

A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Canadian Urological Association Journal
Urology
2017English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pd14-11 Health-Related Quality of Life (Hrql) in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Treated With Cabazitaxel (Cbz) in a Prospective Observational Study (Capristana)

Journal of Urology
Urology
2018English

Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2014English

Pcn40 - A Retrospective Study on Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Prescribed Abiraterone Acetate + Prednisone Prior to Chemotherapy in Sweden, Norway and Denmark

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy